Tarsus Pharmaceuticals, Inc. (TARS) Earnings
NASDAQ·Healthcare·Biotechnology
$61.12
-0.33%
Mkt Cap $2.52B
EPS — Estimate vs Actual
Mkt Cap
$2.52B
P/E
—
Fwd P/E
—
P/S
4.71
Rev TTM
—
EPS TTM
-$1.14
NASDAQ·Healthcare·Biotechnology
$61.12
-0.33%
Mkt Cap $2.52B
Mkt Cap
$2.52B
P/E
—
Fwd P/E
—
P/S
4.71
Rev TTM
—
EPS TTM
-$1.14